Vanguard Group’s Medidata Solutions, Inc. MDSO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-5,537,065
Closed -$507M 4192
2019
Q3
$507M Buy
5,537,065
+71,189
+1% +$6.5M 0.02% 778
2019
Q2
$495M Sell
5,465,876
-96,585
-2% -$8.48M 0.02% 801
2019
Q1
$407M Buy
5,562,461
+118,033
+2% +$8.52M 0.02% 892
2018
Q4
$367M Buy
5,444,428
+243,684
+5% +$17.2M 0.02% 862
2018
Q3
$381M Buy
5,200,744
+142,687
+3% +$11.4M 0.01% 955
2018
Q2
$407M Buy
5,058,057
+177,595
+4% +$13.3M 0.02% 887
2018
Q1
$307M Buy
4,880,462
+114,816
+2% +$7.64M 0.01% 1021
2017
Q4
$302M Buy
4,765,646
+79,574
+2% +$5.67M 0.01% 1013
2017
Q3
$366M Buy
4,686,072
+120,452
+3% +$9.17M 0.02% 882
2017
Q2
$357M Sell
4,565,620
-309,354
-6% -$21.6M 0.02% 870
2017
Q1
$281M Buy
4,874,974
+235,190
+5% +$12.7M 0.01% 998
2016
Q4
$230M Buy
4,639,784
+139,930
+3% +$7.26M 0.01% 1084
2016
Q3
$251M Buy
4,499,854
+64,013
+1% +$3.39M 0.01% 970
2016
Q2
$208M Buy
4,435,841
+200,142
+5% +$8.72M 0.01% 1035
2016
Q1
$164M Buy
4,235,699
+161,728
+4% +$6.29M 0.01% 1138
2015
Q4
$201M Buy
4,073,971
+86,278
+2% +$3.8M 0.01% 1005
2015
Q3
$168M Buy
3,987,693
+70,213
+2% +$3.57M 0.01% 1107
2015
Q2
$213M Buy
3,917,480
+227,549
+6% +$12.2M 0.01% 1021
2015
Q1
$181M Buy
3,689,931
+168,702
+5% +$7.81M 0.01% 1092
2014
Q4
$168M Buy
3,521,229
+68,702
+2% +$2.97M 0.01% 1078
2014
Q3
$153M Buy
3,452,527
+29,498
+0.9% +$1.31M 0.01% 1098
2014
Q2
$147M Buy
3,423,029
+1,412
+0% +$58.6K 0.01% 1153
2014
Q1
$186M Buy
3,421,617
+141,489
+4% +$8.62M 0.02% 957
2013
Q4
$199M Buy
3,280,128
+145,692
+5% +$8.07M 0.02% 905
2013
Q3
$155M Buy
3,134,436
+168,512
+6% +$7.43M 0.02% 975
2013
Q2
$115M Buy
+2,965,924
New +$96.6M 0.01% 1072

Other funds holding MDSO

Vanguard Group's MDSO Position: Q4 2019 in Review

Vanguard Group sold out of Medidata Solutions, Inc. (MDSO) in Q4 2019, closing a stake of 5,537,065 shares — an estimated $507M sold.

Vanguard Group first reported a position in MDSO in Q2 2013 and held it in 26 quarters. The position peaked at $507M in Q3 2019. 1 fund tracked by Wall St. Rank holds MDSO as of Q4 2019.

  • Vanguard Group reported no remaining Medidata Solutions, Inc. position as of Q4 2019 after selling out during the quarter.
  • Vanguard Group sold 5,537,065 Medidata Solutions, Inc. shares in Q4 2019, an estimated $507M.
  • Vanguard Group first reported a position in Medidata Solutions, Inc. in Q2 2013 and held it in 26 quarters.
  • Vanguard Group's Medidata Solutions, Inc. position peaked at $507M in Q3 2019.
  • 1 fund tracked by Wall St. Rank held Medidata Solutions, Inc. as of Q4 2019.

Based on Vanguard Group's 13F filing for Q4 2019, filed 14 Feb 2020.